IGHG3
Immunoglobulin heavy constant gamma 3
Also known as: IGHG3_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- P01860
- Gene
- IGHG3
- Canonical length
- 446 aa
- Protein class
- Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins
OverviewNCBI Gene
No narrative summary is available for IGHG3 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
446 residues, UniProt reviewed canonical sequence.
>P01860|IGHG3
1 ASTKGPSVFP LAPCSRSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
61 GLYSLSSVVT VPSSSLGTQT YTCNVNHKPS NTKVDKRVEL KTPLGDTTHT CPRCPEPKSC
121 DTPPPCPRCP EPKSCDTPPP CPRCPEPKSC DTPPPCPRCP APELLGGPSV FLFPPKPKDT
181 LMISRTPEVT CVVVDVSHED PEVQFKWYVD GVEVHNAKTK PREEQYNSTF RVVSVLTVLH
241 QDWLNGKEYK CKVSNKALPA PIEKTISKTK GQPREPQVYT LPPSREEMTK NQVSLTCLVK
301 GFYPSDIAVE WESSGQPENN YNTTPPMLDS DGSFFLYSKL TVDKSRWQQG NIFSCSVMHE
361 ALHNRFTQKS LSLSPELQLE ESCAEAQDGE LDGLWTTITI FITLFLLSVC YSATVTFFKV
421 KWIFSSVVDL KQTIIPDYRN MIGQGALocalizationUniProt · AlphaFold · HPA
Whether an antibody against IGHG3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Highest tissue expression
- 1,227 nTPM
Expression across tissuesHPA
Tissue
- spleen: 1,227 nTPM
- tonsil: 872 nTPM
- lymph node: 322 nTPM
- lung: 181 nTPM
- small intestine: 99 nTPM
- thyroid gland: 94 nTPM
Single-cell type
- plasma cells: 329 nCPM
- b-cells: 5.6 nCPM
- renal connecting tubule cells: 3.2 nCPM
- podocytes: 2.3 nCPM
- proximal tubule cells: 1.9 nCPM
- parietal cells: 1.8 nCPM
Immune cell
- memory B-cell: 212 nTPM
- naive B-cell: 65 nTPM
- total PBMC: 21 nTPM
- neutrophil: 0.3 nTPM
- eosinophil: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- medulla oblongata: 5.4 nTPM
- cerebral cortex: 2.8 nTPM
- spinal cord: 2.4 nTPM
- choroid plexus: 1.9 nTPM
- white matter: 1.6 nTPM
- hypothalamus: 1.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IGHG3.
Disease | ImmuneIEDB
Conditions an epitope on IGHG3 was assayed in.
- rheumatoid arthritis B cell
- COVID-19 B cell
OntologyGO
Biological processes
- adaptive immune response
- antibacterial humoral response
- B cell receptor signaling pathway
- complement activation, classical pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IGHG3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IGHG3 as an antibody target. Whether an autoantibody or antibody against IGHG3 could matter depends on whether native IGHG3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IGHG3 is annotated at the cell surface, where native IGHG3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IGHG3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...